Comparative Study
doi: 10.1007/BF02327072.
Ergot alkaloids and phosphodiesterase; 'in vitro' activities in several rat brain areas
- PMID: 6807714
- DOI: 10.1007/BF02327072
Item in Clipboard
Comparative Study
Ergot alkaloids and phosphodiesterase; 'in vitro' activities in several rat brain areas
Experientia.
.
Abstract
The 'in vitro' activity of ergotamine, dihydroergocristine, dihydroergocornine and dihydroergocryptine on the phosphodiesterase system at low and high Km in several rat brain areas was examined. These drugs were found to exert an inhibitory effect in all the areas examined with regard to both systems, and particularly on low substrate concentration phosphodiesterases.
Similar articles
-
Interaction of ergot alkaloids and their combination (co-dergocrine) with alpha-adrenoceptors in the CNS.Eur J Pharmacol. 1983 Sep 30;93(3-4):159-68. doi: 10.1016/0014-2999(83)90133-4. Eur J Pharmacol. 1983. PMID: 6315449
-
Influence of some ergot alkaloids on the cerebral reduced glutathione.Farmaco Sci. 1988 Nov;43(11):887-90. Farmaco Sci. 1988. PMID: 3150835
-
[Effects of hydergin on the experimental gangrene of the rat tail caused by ergotamine; correlations between genuine and hydrogenated ergot alkaloids].Arch Int Pharmacodyn Ther. 1952;90(2-3):159-68. Arch Int Pharmacodyn Ther. 1952. PMID: 12977394 Undetermined Language. No abstract available.
-
Pharmacology of ergot alkaloids in clinical use.Med J Aust. 1978 Nov 4;2(3 Suppl):3-13. doi: 10.5694/j.1326-5377.1978.tb77379.x. Med J Aust. 1978. PMID: 370528 Review. No abstract available.
-
Ergot alkaloids and cyclic nucleotides in the CNS.Pharmacology. 1978;16 Suppl 1:150-55. doi: 10.1159/000136816. Pharmacology. 1978. PMID: 205889 Review.
Cited by
-
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.Psychopharmacology (Berl). 1990;101(2):147-59. doi: 10.1007/BF02244119. Psychopharmacology (Berl). 1990. PMID: 2190256 Review.